Juno: How Can CAR-T’s Big Loser Still Be Worth $2.5B? – Seeking Alpha
Seeking Alpha |
Juno: How Can CAR–T’s Big Loser Still Be Worth $2.5B?
Seeking Alpha Novartis and Kite submitted applications to the FDA in March for Chimeric Antigen Receptor Engineered T cells targeting CD19 positive B cell leukemia and lymphoma, respectively. What would have been a Juno Therapeutics CD19 CAR-T candidate for … |
Huffington Post |
Should CRISPR Scientists Play God?
Huffington Post Will genome editing with the new technology, CRISPR, usher in a new era of Promethean overreach? CRISPR makes altering the human genome widely available and cheap. But the fur is rising on the necks of anti-play-god bioethicists; they fear that … CRISPR and CRISPR-Associated (Cas) Genes Market Consumption Analysis, Growth Forecast by Manufacturers …MilTech CRISPR And Cas Genes Market Is Anticipated To Drive Industrial Growth Due To Rising In Adoption Of Latest …satPRnews (press release) How Scientists Explore Our Genome’s ‘Dark Matter’ValueWalk |
UPI.com |
Stem cell consortium tackles complex genetic diseases
Science Daily Much of stem cell research over the past decade has focused on Mendelian disorders — those caused by a single gene, such as cystic fibrosis, muscular dystrophy, and Huntington’s disease. But as genome-wide association studies continue to reveal, most … Scientists announce breakthrough in stem cell researchUPI.com First Clinic-Ready Stem Cell RepositoryThe Scientist Can Stem Cell ‘Patch’ Help Heart Failure?WebMD Medical News Today –UC San Diego Health –Engadget all 91 news articles » |
UPI.com |
Stem cell consortium tackles complex genetic diseases
Science Daily Much of stem cell research over the past decade has focused on Mendelian disorders — those caused by a single gene, such as cystic fibrosis, muscular dystrophy, and Huntington’s disease. But as genome-wide association studies continue to reveal, most … Scientists announce breakthrough in stem cell researchUPI.com First Clinic-Ready Stem Cell RepositoryThe Scientist Can Stem Cell ‘Patch’ Help Heart Failure?WebMD Medical News Today –UC San Diego Health –Engadget all 91 news articles » |
Medical Xpress |
Combo Rx plus stem–cell tx ups PFS in multiple myeloma
Medical Xpress (HealthDay)—Combination therapy with lenalidomide, bortezomib, and dexamethasone (RVD) plus stem–cell transplantation is associated with longer progression-free survival than RVD alone for adults with multiple myeloma, according to a study published … |
|
PET radiotracer design for monitoring targeted immunotherapy
Medical Xpress A drug that blocks a cancer’s inhibitory checkpoint molecules is called an immune checkpoint inhibitor and this form of immunotherapy has emerged as a promising cancer treatment approach. However, the lack of imaging tools to assess immune checkpoint … |